Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
22.92 USD | -1.76% | -2.60% | -23.72% |
05:42pm | UBS Adjusts Rocket Pharmaceuticals Price Target to $51 From $54, Maintains Buy Rating | MT |
03:30pm | Rocket Pharmaceuticals Says Blood Disorder Therapies Show Promise | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-23.72% | 2.12B | |
+3.31% | 108B | |
+11.02% | 104B | |
+1.28% | 22.33B | |
-11.96% | 22.19B | |
-7.05% | 18.69B | |
-38.36% | 17.74B | |
-9.90% | 17.64B | |
+4.32% | 14.05B | |
+34.61% | 12.51B |
- Stock Market
- Equities
- RCKT Stock
- News Rocket Pharmaceuticals, Inc.
- Top Midday Gainers